12 research outputs found

    The long non-coding RNA MALAT1 regulates intestine host-microbe interactions and polyposis

    Get PDF
    The long non-coding RNA (lncRNA) Metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) maintains the integrity of the intestinal epithelial barrier and regulates local inflammation. However, its influences on intestinal microbial communities and tissue susceptibility to cancer development remain unexplored. Here, we report that MALAT1 regulates host anti-microbial response gene expression and the composition of mucosal-associated microbial communities in a region-specific manner. In the APC mutant mouse model of intestine tumorigenesis, knocking out MALAT1 results in higher polyp counts in the small intestine and colon. Interestingly, intestine polyps that developed in the absence of MALAT1 were smaller in size. These findings highlight the unexpected bivalent role of MALAT1 in restricting and promoting cancer progression at different disease stages. Among the 30 MALAT1-targets shared by both the small intestine and colon, ZNF638 and SENP8 levels are predictive of colon adenoma patient overall survival and disease-free survival. Genomic assays further revealed that MALAT1 modulates intestinal target expression and splicing through both direct and indirect mechanisms. This study expands the role of lncRNAs in regulating intestine homeostasis, microbial communities, and cancer pathogenesis

    Regulating inflammation : nuclear receptor and nuclear actin crosstalk at the nuclear receptor co-repressor and coronin 2A checkpoint

    No full text
    Toll-like receptors (TLRs) play important roles as initiators of inflammation through their ability to sense pathogen-associated molecular patterns and products of tissue damage. Activation of TLRs leads to de-repression and subsequent activation of inflammatory response genes that play essential roles in innate and acquired immunity. Derepression of TLR responsive genes involves active removal of the NCoR co-repressor complexes from target gene promoters to relieve basal repression, but the mechanisms remain poorly understood. Here, we report that TLR4 utilizes NFkB to deliver IKKe ; to target promoters that contain ìntegrated circuits' of kB and AP-1 sites, resulting in local phosphorylation of c-Jun and subsequent NCoR clearance. Ligand-dependent SUMOylation of liver X receptors (LXRs) potently suppresses TLR4-induced transcription by preventing the NCoR clearance step, but the underlying mechanisms remain enigmatic. Here, we provide evidence that Coronin 2A (Coro2A), a component of the NCoR complex of previously unknown function, mediates TLR-induced NCoR turnover by a mechanism involving interaction with oligomeric nuclear actin and SUMOylated LXRs block NCoR turnover by binding to a conserved SUMO2/3 interaction motif in Coro2A and preventing actin recruitment. Different from TLR4 signalling, TLR2 ligand leads to rapid activation of CaMKII and phosphorylation of the TBLR1 component of NCoR complexes, bypassing the requirement for c-Jun-phosphorylation and enabling NCoR clearance from promoters lacking integrated kB elements. Intriguingly, while the TLR4-IKKe-dependent clearance pathway is sensitive to transrepression by Liver X Receptors, the TLR2-CaMKII-dependent pathway is not. We found that CaMKIIg-dependent phosphorylation of LXR leads to its deSUMOylation by the SUMO protease SENP3 and release from Coro2A. Together, these findings reveal a Coro2A/actin-dependent mechanism for de-repression of inflammatory response genes that can be differentially regulated by kinase-phosphorylation and nuclear receptor signaling pathways that underlie pathogen-specific responses and disease-specific programs of inflammatio
    corecore